| Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy (NCT00702741) | Mesoblast International Sàrl | 2008-06-01 |
| A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer (NCT00736372) | Cascadian Therapeutics Inc. | 2008-06-01 |
| Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal. (NCT00812318) | ViiV Healthcare | 2008-06-01 |
| Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers (NCT00699504) | The Medicines Company | 2008-06-01 |
| Combination Therapy in Amyotrophic Lateral Sclerosis (ALS) (NCT00919555) | Phoenix Neurological Associates, LTD | 2008-06-01 |
| Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) (NCT00712790) | Singapore Clinical Research Institute | 2008-06-01 |
| Raltegravir and Ezetimibe PK Study (NCT00772551) | St Stephens Aids Trust | 2008-06-01 |
| Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers (NCT02183402) | Boehringer Ingelheim | 2008-06-01 |
| Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine (NCT00717834) | Alachua Government Services, Inc. | 2008-06-01 |
| Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma (NCT00722488) | Millennium Pharmaceuticals, Inc. | 2008-06-01 |
| Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma (NCT00716495) | AGIRx Ltd. | 2008-06-01 |
| A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily) (NCT01121900) | Labopharm Inc. | 2008-06-01 |
| Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours (NCT00710268) | AstraZeneca | 2008-06-01 |
| Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers (NCT00711074) | AstraZeneca | 2008-06-01 |
| A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED) (NCT00772967) | Merck Sharp & Dohme LLC | 2008-06-01 |
| Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes (NCT01464099) | Novo Nordisk A/S | 2008-06-01 |
| Administration of BIIB028 to Subjects With Solid Tumors (NCT00725933) | Biogen | 2008-06-01 |
| Intradiscal rhGDF-5 Phase I/II Clinical Trial (NCT00813813) | DePuy Spine | 2008-06-01 |
| A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer (NCT00710736) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-06-01 |
| Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies (NCT00691210) | Columbia University | 2008-06-01 |
| Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT00725062) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets. (NCT00713791) | AstraZeneca | 2008-06-01 |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors (NCT00625456) | Jennerex Biotherapeutics | 2008-06-01 |
| Cone Beam Computed Tomography for Breast Imaging (NCT00972413) | Koning Corporation | 2008-06-01 |
| TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. (NCT00741169) | Tibotec Pharmaceuticals, Ireland | 2008-06-01 |
| Antagonist/Letrozole in Poor Responders (NCT00823004) | Yazd Research & Clinical Center for Infertility | 2008-06-01 |
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma. (NCT00688090) | Mannkind Corporation | 2008-06-01 |
| Transplantation of Pancreatic Islets in Patients With Type 1 Diabetes Mellitus and Functional Kidney Graft (NCT00639600) | University Hospital, Grenoble | 2008-06-01 |
| Raltegravir as Early Therapy in African-Americans Living With HIV Study (NCT00667433) | David A Wohl, MD | 2008-06-01 |
| Injectable Bulking Agent Needle Guide (NCT00763711) | Carbon Medical Technologies | 2008-06-01 |
| Cervical Device Contraception-2 (Nanopaz) (NCT00689494) | Bnai Zion Medical Center | 2008-06-01 |
| Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease (NCT00801307) | Air Liquide SA | 2008-06-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein (NCT00755924) | HealthPartners Institute | 2008-06-01 |
| Varenicline to Reduce Alcohol Consumption in Heavy Drinkers (NCT00695500) | Vijay Ramchandani, Ph.D. | 2008-06-01 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174) | National Cancer Institute (NCI) | 2008-06-01 |
| Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00684996) | National Cancer Institute (NCI) | 2008-06-01 |
| Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies (NCT00710528) | Gilead Sciences | 2008-06-01 |
| Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese (NCT00738959) | AstraZeneca | 2008-06-01 |
| The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism (NCT00695136) | National Institute of Mental Health (NIMH) | 2008-06-01 |
| Phase I Study of TAS-106 in Combo With Carboplatin (NCT00752011) | M.D. Anderson Cancer Center | 2008-06-01 |
| Phase I Trial of Oral PX-866 (NCT00726583) | Cascadian Therapeutics Inc. | 2008-06-01 |
| A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells (NCT00703222) | Baylor College of Medicine | 2008-06-01 |
| A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone (NCT00864214) | Mayo Clinic | 2008-06-01 |
| AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours (NCT00704366) | AstraZeneca | 2008-06-01 |
| Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon (NCT00700518) | Procris Pharmaceuticals | 2008-06-01 |
| A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma (NCT00724841) | Gemin X | 2008-06-01 |
| The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy (NCT00696410) | University of Michigan | 2008-06-01 |
| A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors. (NCT00721266) | Hoffmann-La Roche | 2008-06-01 |
| A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants (NCT00686075) | MedImmune LLC | 2008-06-01 |
| Myocardial Protection With Adenosine Preconditioning (NCT00881686) | Xijing Hospital | 2008-06-01 |
| Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours (NCT00702494) | BioInvent International AB | 2008-06-01 |
| Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers (NCT02182453) | Boehringer Ingelheim | 2008-06-01 |
| Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma (NCT00671112) | Brian Hill, MD, PhD | 2008-06-01 |
| Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) (NCT01211626) | Hoffmann-La Roche | 2008-06-01 |
| Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy (NCT00755911) | University of Michigan | 2008-06-01 |
| Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant (NCT00697684) | Beth Israel Deaconess Medical Center | 2008-06-01 |
| Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions (NCT01210638) | Roxane Laboratories | 2008-06-01 |
| Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer (NCT00870532) | National Cancer Centre, Singapore | 2008-06-01 |
| Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma (NCT00861783) | Traws Pharma, Inc. | 2008-06-01 |
| Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma (NCT00765921) | Massachusetts Eye and Ear Infirmary | 2008-06-01 |
| Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor (NCT00706576) | University of Missouri-Columbia | 2008-06-01 |
| VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state. (NCT00775125) | Tibotec BVBA | 2008-06-01 |
| A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (NCT00712855) | Human Genome Sciences Inc., a GSK Company | 2008-06-01 |
| Adalimumab for Inflammatory Osteoarthritis (NCT00686439) | University of Alberta | 2008-06-01 |
| LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML) (NCT00691938) | Washington University School of Medicine | 2008-06-01 |
| Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00714181) | Abramson Cancer Center at Penn Medicine | 2008-06-01 |
| A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors (NCT00784914) | City of Hope Medical Center | 2008-06-01 |
| Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant (NCT00662272) | Colby Pharmaceutical Company | 2008-06-01 |
| Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis (NCT00835510) | Sun Pharmaceutical Industries, Inc. | 2008-06-01 |
| Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056 (NCT00700986) | AstraZeneca | 2008-06-01 |
| Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval (NCT00713336) | AstraZeneca | 2008-06-01 |
| Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers (NCT00660153) | AVEO Pharmaceuticals, Inc. | 2008-06-01 |
| Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women (NCT00706225) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-06-01 |
| A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL) (NCT00676871) | MedImmune LLC | 2008-06-01 |
| Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers (NCT00656357) | Biotie Therapies Inc. | 2008-06-01 |
| Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00694590) | Genzyme, a Sanofi Company | 2008-06-01 |
| An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers (NCT00721448) | AstraZeneca | 2008-06-01 |
| Assessment of the Effect of BI 201335 on the QT Interval in Healthy Female and Male Subjects (NCT02182310) | Boehringer Ingelheim | 2008-06-01 |
| Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients (NCT01138111) | Lantheus Biosciences Ltd. | 2008-06-01 |
| Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (NCT00634088) | R-Pharm | 2008-06-01 |
| Bioequivalence Study of Two Imiquimod Cream 5% (NCT00828568) | Sun Pharmaceutical Industries, Inc. | 2008-06-01 |
| Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia (NCT00703300) | National Cancer Institute (NCI) | 2008-06-01 |
| Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) (NCT00986843) | Hanmi Pharmaceutical Company Limited | 2008-06-01 |
| A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer (NCT00754312) | Syndax Pharmaceuticals | 2008-06-01 |
| Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer (NCT00660101) | AVAX Technologies | 2008-06-01 |
| Study of TRC102 in Combination With Pemetrexed in Cancer Patients (NCT00692159) | Tracon Pharmaceuticals Inc. | 2008-06-01 |
| Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers (NCT02182336) | Boehringer Ingelheim | 2008-06-01 |
| A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers (NCT00912262) | NeurogesX | 2008-06-01 |
| Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients (NCT01131364) | Philogen S.p.A. | 2008-06-01 |
| A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza (NCT00706732) | AlphaVax, Inc. | 2008-06-01 |
| Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections (NCT00621192) | The Emmes Company, LLC | 2008-06-01 |
| Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies (NCT00697632) | Mirati Therapeutics Inc. | 2008-06-01 |
| Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission (NCT00963521) | Institut Paoli-Calmettes | 2008-06-01 |
| Visual Training Program to Improve Balance and Prevent Falls in Older Adults (NCT00549406) | Sunnybrook Health Sciences Centre | 2008-06-01 |
| LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors (NCT01159418) | Southern Europe New Drug Organization | 2008-06-01 |
| Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies (NCT00660920) | Ariad Pharmaceuticals | 2008-06-01 |
| Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma (NCT00633594) | SCRI Development Innovations, LLC | 2008-06-01 |
| An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) (NCT00652080) | BPGbio | 2008-06-01 |
| MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma (NCT00833833) | Celgene Corporation | 2008-06-01 |